Insider Trading & Ownership - Stenhouse Mark

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Stenhouse Mark
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-16
Purchase
2021-03-16
9:49 pm
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
14,000$19$266,00014,000
(Direct)
View
2020-04-03
Sale
2020-04-06
4:41 pm
EXACT SCIENCES CORPEXASStenhouse Mark
President, Cologuard
11,948$56.69$677,33254,926
(Indirect
Direct)
View
2020-02-27
Sale
2020-02-28
4:39 pm
EXACT SCIENCES CORPEXASStenhouse Mark
President, Cologuard
1,051$80.27$84,36426,663
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-23
Option Award
2024-05-24
7:18 pm
N/A
2034-05-22
Phathom Pharmaceuticals Inc.PHATStenhouse Mark
Director
28,000$037,000
(Direct)
View
2023-06-16
Disposition
2023-06-16
4:00 pm
N/A
2028-05-22
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
497,792$00
(Direct)
View
2023-06-01
Other
2023-06-02
6:57 pm
N/A
N/A
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
14,000$054,708
(Direct)
View
2023-05-25
Option Award
2023-05-30
7:01 pm
N/A
2033-05-24
Phathom Pharmaceuticals Inc.PHATStenhouse Mark
Director
24,000$024,000
(Direct)
View
2022-12-09
Option Award
2022-12-13
8:38 pm
N/A
2032-12-08
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
43,896$060,527
(Direct)
View
2022-05-25
Option Award
2022-05-27
4:50 pm
N/A
2032-05-24
Phathom Pharmaceuticals Inc.PHATStenhouse Mark
Director
15,000$015,000
(Direct)
View
2022-05-20
Option Award
2022-05-20
7:15 pm
2025-05-20
2032-05-19
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
86,582$086,582
(Direct)
View
2021-11-14
Option Award
2021-11-16
9:10 pm
N/A
2031-11-13
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
70,371$070,371
(Direct)
View
2021-05-21
Option Award
2021-05-24
5:44 pm
N/A
2031-05-20
Phathom Pharmaceuticals Inc.PHATStenhouse Mark
Director
12,500$012,500
(Direct)
View

Ownership
2021-03-11
9:29 pm
2021-02-04
2028-05-22
Prometheus Biosciences Inc.RXDXStenhouse Mark
Chief Operating Officer
0$0280,000
(Direct)
View
2020-04-02
Exercise
2020-04-06
4:41 pm
N/A
N/A
EXACT SCIENCES CORPEXASStenhouse Mark
President, Cologuard
25,000$054,926
(Direct)
View
2020-03-17
Option Award
2020-03-19
4:34 pm
N/A
2030-03-16
Phathom Pharmaceuticals Inc.PHATStenhouse Mark
Director
20,000$020,000
(Direct)
View
2020-02-26
Exercise
2020-02-28
4:39 pm
N/A
N/A
EXACT SCIENCES CORPEXASStenhouse Mark
President, Cologuard
3,262$026,663
(Direct)
View
2020-02-14
Option Award
2020-02-18
4:40 pm
N/A
N/A
EXACT SCIENCES CORPEXASStenhouse Mark
President, Cologuard
25,568$040,039
(Direct)
View